0000899243-20-034885.txt : 20201222
0000899243-20-034885.hdr.sgml : 20201222
20201222192912
ACCESSION NUMBER: 0000899243-20-034885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201218
FILED AS OF DATE: 20201222
DATE AS OF CHANGE: 20201222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilde Healthcare Holding B.V.
CENTRAL INDEX KEY: 0001420106
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 201409437
BUSINESS ADDRESS:
STREET 1: NEWTONLAAN 91
STREET 2: PO BOX 85067
CITY: 3508 UTRECHT
STATE: P7
ZIP: AB
BUSINESS PHONE: 31(0)30-2192549
MAIL ADDRESS:
STREET 1: NEWTONLAAN 91
STREET 2: PO BOX 85067
CITY: 3508 UTRECHT
STATE: P7
ZIP: AB
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilde Healthcare IV Management B.V.
CENTRAL INDEX KEY: 0001757508
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 201409438
BUSINESS ADDRESS:
STREET 1: NEWTONLAAN 91
CITY: UTRECHT
STATE: P7
ZIP: 3584 BP
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: NEWTONLAAN 91
CITY: UTRECHT
STATE: P7
ZIP: 3584 BP
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooperatieve Gilde Healthcare IV U.A.
CENTRAL INDEX KEY: 0001756335
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 201409439
BUSINESS ADDRESS:
STREET 1: NEWTONLANN 51
CITY: UTRECHT
STATE: P7
ZIP: 3508AB
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: NEWTONLANN 51
CITY: UTRECHT
STATE: P7
ZIP: 3508AB
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-18
0
0001531048
Inari Medical, Inc.
NARI
0001756335
Cooperatieve Gilde Healthcare IV U.A.
NEWTONLAAN 91 3584 BP
UTRECHT
P7
NETHERLANDS
0
0
1
0
0001757508
Gilde Healthcare IV Management B.V.
NEWTONLAAN 91 3584 BP
UTRECHT
P7
NETHERLANDS
0
0
1
0
0001420106
Gilde Healthcare Holding B.V.
NEWTONLAAN 91 3584 BP
UTRECHT
P7
NETHERLANDS
0
0
1
0
Common Stock
2020-12-18
4
S
0
63840
70.52
D
6877839
I
See footnote
Common Stock
2020-12-18
4
S
0
110474
71.53
D
6767365
I
See footnote
Common Stock
2020-12-18
4
S
0
41878
72.16
D
6725487
I
See footnote
Common Stock
2020-12-21
4
S
0
11885
70.41
D
6713602
I
See footnote
Common Stock
2020-12-21
4
S
0
13125
71.73
D
6700477
I
See footnote
Common Stock
2020-12-21
4
S
0
54257
72.47
D
6646220
I
See footnote
Common Stock
2020-12-21
4
S
0
71415
73.47
D
6574805
I
See footnote
Common Stock
2020-12-21
4
S
0
44268
74.53
D
6530537
I
See footnote
Common Stock
2020-12-22
4
S
0
20754
76.11
D
6509783
I
See footnote
Common Stock
2020-12-22
4
S
0
71340
77.22
D
6438443
I
See footnote
Common Stock
2020-12-22
4
S
0
98190
78.21
D
6340253
I
See footnote
Common Stock
2020-12-22
4
S
0
4880
78.57
D
6335373
I
See footnote
Common Stock
2020-12-22
4
S
0
4714
74.48
D
6330659
I
See footnote
Common Stock
2020-12-22
4
S
0
5287
76.12
D
6325372
I
See footnote
Common Stock
2020-12-22
4
S
0
43841
77.22
D
6281531
I
See footnote
Common Stock
2020-12-22
4
S
0
6316
77.79
D
6275215
I
See footnote
Common Stock
2020-12-22
4
S
0
28700
78.31
D
6246515
I
See footnote
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.995 inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.435, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.885, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $71.00 to $71.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $73.00 to $73.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $74.00 to $74.795, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $75.605 to $76.59, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $76.605 to $77.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $77.605 to $78.50, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $78.51 to $78.68, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $74.09 to $74.71, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $75.645 to $76.625, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $76.6675 to $77.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $77.67 to $77.995, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.81, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Cooperatieve Gilde Healthcare IV U.A., By: /s/ Marc Perret, Name: Marc Perret, Title: Managing Director
2020-12-22
Gilde Healthcare IV Management B.V., By: /s/ Marc Perret, Name: Marc Perret, Title: Managing Director
2020-12-22
Gilde Healthcare Holding B.V., By: /s/ Marc Perret, Name: Marc Perret, Title: Managing Director
2020-12-22